Stay updated with breaking news from Marks Levine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Several brokerages have updated their recommendations and price targets on shares of Immunovant (NASDAQ: IMVT) in the last few weeks: 10/13/2023 – Immunovant was upgraded by analysts at UBS Group AG from a “neutral” rating to a “buy” rating. They now have a $55.00 price target on the stock, up previously from $18.00. 10/9/2023 – […]
Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) insider Mark S. Levine sold 3,917 shares of the company’s stock in a transaction on Wednesday, July 26th. The stock was sold at an average price of $21.63, for a total transaction of $84,724.71. Following the completion of the transaction, the insider now owns 326,774 shares of the […]
Immunovant, Inc. (NASDAQ:IMVT – Get Rating)’s share price was down 3.1% during mid-day trading on Wednesday . The company traded as low as $15.70 and last traded at $15.70. Approximately 51,566 shares traded hands during trading, a decline of 95% from the average daily volume of 1,023,167 shares. The stock had previously closed at $16.21. […]